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TgaA, a VirB1-Like Component Belonging to a Putative Type IV
Secretion System of Bifidobacterium bifidum MIMBb75
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Alessandro Ciranna,d Stefania Arioli,a Ville Santala,d Stefania Iametti,a Francesco Bonomi,a Marco Ventura,b Diego Mora,a Matti Karpd
Department of Food Environmental and Nutritional Sciences, Università degli Studi di Milano, Milan, Italya; Laboratory of Probiogenomics, Department of Life Sciences,
University of Parma, Parma, Italyb; IRCCS Policlinico San Matteo, Pavia, Italyc; Department of Chemistry and Bioengineering, Tampere University of Technology, Tampere,
Finlandd
Bifidobacterium bifidum MIMBb75 is a human intestinal isolate demonstrated to be interactive with the host and efficacious as a
probiotic. However, the molecular biology of this microorganism is yet largely unknown. For this reason, we undertook whole-
genome sequencing of B. bifidum MIMBb75 to identify potential genetic factors that would explain the metabolic and probiotic
attributes of this bacterium. Comparative genomic analysis revealed a 45-kb chromosomal region that comprises 19 putative
genes coding for a potential type IV secretion system (T4SS). Thus, we undertook the initial characterization of this genetic re-
gion by studying the putative virB1-like gene, named tgaA. Gene tgaA encodes a peptidoglycan lytic enzyme containing two ac-
tive domains: lytic murein transglycosylase (LT, cd00254.3) and cysteine- and histidine-dependent amidohydrolase/peptidase
(CHAP, pfam05257.4). By means of several in vitro assays, we experimentally confirmed that protein TgaA, consistent with its
computationally assigned role, has peptidoglycan lytic activity, which is principally associated to the LT domain. Furthermore,
immunofluorescence and immunogold labeling showed that the protein TgaA is abundantly expressed on the cell surface of B.
bifidumMIMBb75. According to the literature, the T4SSs, which have not been characterized before in bifidobacteria, can have
important implications for bacterial cell-to-cell communication as well as cross talk with host cells, justifying the interest for
further studies aimed at the investigation of this genetic region.
Bifidobacteria are Gram-positive members of the human gutmicrobiota that include species typically representing the
dominant colonic bacteria in breast-fed infants (1, 2). Together
with lactobacilli, bifidobacteria are the microorganisms most
widely exploited in probiotic formulations because of their vari-
ous health-promoting properties. In this regard, the ability of Bi-
fidobacterium to interact with the host has been demonstrated to
be species and strain specific (3–5). Notably, members of the spe-
cies Bifidobacterium bifidum are capable of interaction with the
host, including degradation of mucin (6, 7), metabolism of hu-
man milk oligosaccharides (8), and modulation of host immune
responses (9–11). Therefore, the species B. bifidum represents a
good source of bacterial strains to be employed for the develop-
ment of novel effective probiotic (12) or paraprobiotic (13) prod-
ucts.
B. bifidum MIMBb75 is a human intestinal isolate with a
marked ability to adhere to intestinal mucosae (6, 8), transiently
colonize murine intestine, and impact the resident microbial
communities (14). Furthermore, the probiotic potential of this
strain was evidenced in a clinical trial in which daily consumption
of B. bifidum MIMBb75 significantly alleviated the global symp-
toms of irritable bowel syndrome and improved the quality of life
(15). Though MIMBb75 is efficacious as a probiotic, the molecu-
lar mechanisms underlying such interaction are yet largely un-
known. For this reason, we undertook whole-genome sequencing
of MIMBb75 to identify potential genetic factors useful to eluci-
date the metabolic and probiotic potentialities of this bacterium.
Type IV secretion systems (T4SSs) are large bacterial protein
complexes that transportmacromolecules across the cell envelope
(16). Reportedly, T4SSs are involved in naked DNA uptake and
release (17), conjugation (18), and delivery of effector molecules
(DNA and/or protein) into eukaryotic host cells (19). To support
these activities, the proteins constituting T4SSs include (i) pepti-
doglycan lytic enzymes, (ii) energizing (motor) components, (ii)
scaffold/putative core components, and (iv) surface factors/ad-
hesins (20). T4SSs have been studied in detail in certain Gram-
negative bacteria, which use these conjugation apparatuses for the
translocation of genetic material and effector proteins into other
bacteria or eukaryotic host cells (19). In contrast, T4SSs described
so far inGram-positive bacteria appear to be exclusively dedicated
to conjugative DNA transfer, as demonstrated by the presence of
members of an additional family of DNA processing enzymes not
present in T4SSs participating in protein effector transport (20).
Furthermore, Gram-positive conjugative T4SSs do not produce
pilus filaments but contain surface proteins that operate as ad-
hesins (21). It is plausible that T4SSs in Gram-positive cells serve
additional and yet unknown purposes.
Although identified in the genome of numerous Gram-posi-
tive bacteria, T4SSs have not been characterized in bifidobacteria.
In this regard, here we show the identification by comparative
genomics of a genetic region putatively coding for a type IV secre-
tion system in B. bifidum MIMBb75. As a first step in the charac-
terization of the putative T4SS of strain MIMBb75, in this study,
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we describe the molecular analysis of one of its constitutive ele-
ments, namely, the putative VirB1-like peptidoglycan-lytic com-
ponent encoded by gene tgaA. In addition, gene tgaA attracted our
attention because its product probably is located on the outer
surface of the bacterial cells and therefore has major chances to
interact with host cells.
MATERIALS AND METHODS
Bifidobacterial culture conditions. Bifidobacterium strains were grown
under anaerobic condition (Anaerocult A System; Merck, Darmstadt,
Germany) at 37°C in prereduced DeMan-Rogosa-Sharpe (MRS) broth
(Difco Laboratories, Inc., Detroit, MI) supplemented with 0.05% L-cys-
teine hydrochloride (cMRS; Sigma-Aldrich, St. Louis, MO).
Genome sequencing, sequence annotation, and comparative analy-
sis. The genome sequence of B. bifidum MIMBb75 was determined by
the use of an Illumina HiSeq 2000 system with paired-end and shotgun
libraries. A total of 5,722,028 reads with an average length of 35 bp
were assembled into 133 contigs using SOAPde novo, version 1.04,
software (22). Protein-encoding open reading frames (ORFs) were
predicted using a combination of Prodigal (23) and BLASTX (24) for
comparative analysis. Results of the gene-finder program were com-
bined manually with data from BLASTP (25) analysis against a nonre-
dundant protein database provided by the National Center for Bio-
technology Information. The combined results were inspected by
Artemis (26), which was used for a manual editing effort to verify and,
if necessary, to redefine the start of each predicted coding region or to
remove or add coding regions within the 45-kb region containing the
tgaA gene (i.e., the putative type IV secretion system region [T4SS]).
The TMHMM server, version 2.0 (27), was used to predict transmem-
brane sequences, and SignalP (28) was used for the prediction of signal
peptides. Whole-genome sequence alignments for similarity were per-
formed at the DNA level using LAST (http://last.cbrc.jp/).
tgaA gene expression analysis. Total RNA was extracted from B. bifi-
dum MIMBb75 collected at the early logarithmic (optical density at 600
nm [OD600] of 0.5 to 1), late logarithmic (OD600 of 2 to 2.5), and station-
ary (OD600 of 2.5 to 3) growth phases as previously described (29). In
brief, a volume of cMRS broth culture containing 109 cells was collected
and centrifuged (at 4°C for 1 min at 8,000  g). The pellet was resus-
pended in 1 ml of PureZol (Bio-Rad Laboratories, Milan, Italy) and sub-
jected to amechanical disruption using a Precellys bead beater (Advanced
Biotech Italia s.r.l., Seveso, Italy). Total RNA extraction was performed
with an Aurum Total RNA Fatty and Fibrous Tissue kit (Bio-Rad Labo-
ratories), and samples were additionally treated with DNase I (Sigma-
Aldrich) for 30min at room temperature. Subsequently, iScriptTMcDNA
Synthesis (Bio-Rad Laboratories) was used to obtain cDNA from 1 g of
RNA. Finally, PCR was carried out using a volume of cDNA solution
corresponding to 15 ng of initial RNA in a total reaction volume of 25 l
using DreamTaq DNA polymerase (Fermentas, Vilnius, Lithuania). The
expression level of the gene tgaA was assessed with primers Cha-F (5=-C
GGCGACGTGATCTGCTTCGA-3=) and Cha-R (5=-CCGGATTGGCTG
ATGAGGATC-3=), which allow the amplification of a 115-bp tgaA inter-
nal fragment. Internal normalization was obtained through the
amplification of an approximately 500-bp fragment from the 16S rRNA
gene with primers g-Bifid-F (5=-CTCCTGGAAACGGGTGG-3=) and g-
Bifid-R (5=-GGTGTTCTTCCCGATATCTACA-3=). Annealing tempera-
tures in the PCR were 60°C and 55°C for the Cha and g-Bifid primers,
respectively.
Expression of TgaA-derived recombinant proteins in Escherichia
coli. All enzymes and reagents for molecular biology reactions (poly-
merases, T4 ligase, and restriction enzymes) were from Fermentas or New
England BioLabs (EuroClone S.p.A., Pero, Italy). Purification of PCR
fragments was performed with UltraClean PCRCleanup (MoBio Labora-
tories/Cabru s.a.s., Arcore, Italy). Plasmid extraction from E. coliwas car-
ried out with a QIAprep Spin miniprep kit (Qiagen s.r.l., Milan, Italy).
DNA fragments in agarose gel were extracted and purified with a
QIAquick gel extraction kit (Qiagen). Antibiotics for the selection of plas-
mids were from Sigma-Aldrich (St. Louis, MO). For the preparation of
vector pAK-tga, the gene tgaA (without the original signal peptide [SP])
was amplified by PCR from B. bifidum MIMBb75 chromosomal DNA
with primers tgaFOR-MA (5=-TTACTCGCGGCCCAGCCGGCCATGG
CGACGGAATCCACGGTC-3=) and tgaREV (5=-ATGGTGATCGGCCC
CCGAGGCCGTGTGAATGAAGCTGACGCT-3=). The ampliconwas di-
gested with SfiI restriction enzyme (SfiI restriction sites in the primers are
underlined) and ligated in the same restriction site of vector pAK400 (30),
yielding a transcriptional fusion of the tgaA amplicon with an E. coli pelB
signal sequence (SPpelB) that was present in vector pAK400. The ligation
mix was used to transform E. coli JM109 by electroporation according to
standard protocols. Recombinants of E. coli JM109 were cultured at 37°C
in Super Optimal Broth (SOB) medium supplemented with 25 g ml1
chloramphenicol. Once expressed, the signal peptide SPPelB allows the
export of the recombinant protein to the periplasm of E. coli cells. For the
overexpression of TgaA recombinant proteins, we prepared three plas-
mids based on expression vector pET26b() (Novagen/Merck KGaA,
Darmstadt, Germany) and the expression host E. coli BL21(DE3) pLysS
(Promega, Madison, WI, USA). In detail, gene tgaA (without the original
signal peptide) was amplified by PCR from B. bifidum MIMBb75 chro-
mosomal DNA with primers TgaNdeF (5=-CCTTGGAACATATGAGCG
AATCCACGGTCG-3=) andTgaHindR (5=-TCTAGGAAAAGCTTGTGA
ATGAAGCTGACG-3=), which include restriction sites NdeI and BamHI,
respectively (underlined). The resulting amplicon was digested and li-
gated in the same restriction sites of vector pET26b(), yielding a tran-
scriptional fusion with a six-His tag at the 3= terminus of the gene. The
resulting vector, named pET-Tga, was subsequently digested with Bsp19I,
yielding two DNA fragments. The larger fragment (containing the vector
replicon) was separated in and purified from agarose gel and finally self-
ligated, yielding vector pET-CHAP (where CHAP is cysteine- and histi-
dine-dependent amidohydrolase/peptidase, pfam05257.4). Afterwards,
we prepared vector pET-LT (where LT is lytic murein transglycosylase,
cd00254.3) by inverse PCR amplification of plasmid pET-Tga with prim-
ers dLT-F (5=-ATACCGGAATTCACGGAGACCACCA-3=) and dLT-R
(5=-TTCCAATTGAATTCCTGGTCGATCT-3=), followed by digestion of
the amplicon with EcoRI (the restriction site is underlined in primer se-
quences), and self-ligation. The recombinants of E. coli BL21(DE3) pLysS
were cultured at 37°C in the presence of 25 g ml1 chloramphenicol
(selection for pLysS plasmid) and 25 g ml1 kanamycin (selection for
pET vectors). The absence of mutations or recombinations in the ob-
tained plasmids was confirmed by sequencing analysis. Vectors pAK-Tga,
pET-CHAP, and pET-LT were used for the overexpression of the
TgaA-derived recombinant proteins.
Analysis of intracellular accumulation of cell wall breakdownprod-
ucts. In order to determine the accumulation of fragments deriving from
cell wall lysis in E. coli cells, we used the bioluminescence reporter system
based on vector pBlaLux1 and E. coli SNO301 (31). Briefly, we trans-
formed by electroporation the cell reporter system with vector pAK-Tga.
The expression of TgaA recombinant protein frompAK-Tgawas obtained
by adding isopropyl-D-1-thiogalactopyranoside (IPTG; Sigma-Aldrich)
to the cell culture. To assess cell wall lysis, immediately after IPTG addi-
tion, the broth cultures were aliquoted in amicrotiter plate and incubated
at 37°C in a luminometer (Chameleon Multilabel Detection Platform;
Hidex OY, Turku, Finland) that was set to automatically measure light
emission every 5 min for several hours.
Protein overproduction. Vectors pAK-Tga, pET-CHAP, and pET-
LT were used to overexpress in E. coli the recombinant proteins SP-
TgaA-His (containing both domains of TgaA protein; also named SPPelB-
TgaA here and rTgaA for recombinant TgaA in an accompanying paper
[32]), protein SP-TgaA-CHAP-His (containing only the LT domain;
rLT), and SP-TgaA-LT-His (containing only the CHAP domain;
rCHAP), respectively. To this aim, recombinant E. coli strains were grown
over night in 2 YT (yeast extract, tryptone) broth at 37°C and then
Guglielmetti et al.
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inoculated in 200 ml of the same medium (1:100 inoculum). After 2 h of
incubation under strong agitation at 37°C, 1 mM IPTG was added, and
incubation was prolonged for 4 h. Afterwards, cells were recovered by
centrifugation, weighed, and treated for protein extraction under dena-
turing conditions with PerfectPro Ni-nitrilotriacetic acid (NTA) agarose
(5 Prime; Eppendorf Italia s.r.l., Milan, Italy) according to the manufac-
turer’s instructions.
Detection of peptidoglycan lytic activity by renaturing SDS-PAGE.
Renaturing SDS-PAGEwas performed as described byMora et al. (33). In
brief, autoclaved cells of Micrococcus luteus ATCC 4698 (Sigma-Aldrich)
were polymerized using a 12% SDS-PAGE gel at a concentration of 0.2%
(wt/vol). Sample preparation was carried out by mixing 5 g of recombi-
nant protein with 30 l of SDS-PAGE denaturing loading buffer. After
electrophoresis, gels were soaked in 200ml of sterilized, distilled water for
30min and then in 200ml of 25mmol liter1 Tris-HCl (pH 7) containing
1% (wt/vol) Triton X-100 for 12 to 36 h. Bands of lytic activity were
visualized by staining the gel with 1% (wt/vol) methylene blue (Sigma) in
0.1% (wt/vol) KOH and subsequent destaining in sterilized distilled
water.
Generation of SP-TgaA-LT-His-specific antibodies. An anti-
body against the recombinant protein rCHAP was raised in rabbits by
Primm s.r.l. (Milan, Italy). Briefly, after preimmune serum collection,
an initial immunization was followed by a second immunization at day
21, a third immunization at day 28, a bleed step and enzyme-linked
immunosorbent assay (ELISA) at day 35, and a fourth immunization
at day 37. Then, a final serum sampling and affinity purification of
antibodies were carried out.
Preparationandanalysis of immunofluorescentB.bifidumMIMBb75.B.
bifidum MIMBb75 cells were cultivated until early stationary growth
phase, harvested by centrifugation, washed once with deionized sterile
water, and incubated at room temperature for 10 min with SP-TgaA-
LT-His antiserum (1:100 diluted in deionized water). Subsequently,
bacterial cells were centrifuged, resuspended in a solution of Cy5-conju-
gated goat anti-rabbit secondary antibody (Molecular Probes, Eugene,
OR) (1:10 diluted in deionized water), and incubated for 10 min at room
temperature in the dark. Afterwards, stained cells were visualized with a
fluorescence optical digital microscope (Leica DM1000; LeicaMicro-Sys-
tems, Wetzlar, Germany) at a magnification of1,000.
Electronmicroscopy and immunogold labeling. Bifidobacterial cells
were cultivated in broth to stationary phase (15 to 18 h of cultivation) or
on agar plates of cMRS medium. Bacterial cells were collected, and the
resulting pellet was processed for transmission electronmicroscopy. Sam-
ple preparationwas performed according toArioli et al. (34). In brief, cells
were fixed in 2.5% glutaraldehyde and later postfixed with 1% osmium
tetroxide (in 0.1Mcacodylate buffer, pH7.2) for 2 h at room temperature.
After the remaining osmium tetroxide was eliminated, the samples were
dehydrated in a graduated cold ethanol series (35 to 100%); each step was
performed for about 10 to 15 min at room temperature. The fixed cells
were embedded in Epon 812. Blocks were cut with an ultramicrotome and
collected onnickel grids. Sectionswere poststainedwith 5%uranyl acetate
for 5 min at room temperature and treated with lead citrate for 1 min.
Sections were observed and photographed with a Philips CM 12 electron
microscope and a Zeiss 900 (Carl Zeiss S.p.A., Arese, Milan, Italy). Bacte-
rial cells were also observed after direct staining (intact-cell analysis). For
immunogold electronmicroscopy analysis, samples were treated with an-
ti-SP-TgaA-LT-His rabbit immune serum (or preimmune serum),
and the antibodies were then labeled with protein A-conjugated gold par-
ticles (10 nm). Finally, the samples were negatively stained with uranyl
acetate and lead citrate as indicated above and examined under an elec-
tron microscope.
Nucleotide sequence accession number. The DNA sequence of the
T4SS region from B. bifidum MIMBb75 has been deposited in the EMBL
database under the accession number HG794715.
RESULTS AND DISCUSSION
In silico analysis of the B. bifidum MIMBb75 genome reveals a
chromosomal region putatively coding for a type IV secretion
system.Wegenerated a draft genome sequence ofBifidobacterium
bifidum MIMBb75 consisting of 133 contigs, which in total con-
tained 2.25 Mbp. The guanine and cytosine (GC) content was
calculated to be 62.76%, which is consistent with that of other B.
bifidum genomes (7).
Comparative genomics revealed that more than 90% of the
putative coding sequences identified in MIMBb75’s contigs
share high sequence homology with all of the B. bifidum ge-
nomes available so far (GenBank accession numbers: strain
BGN4, NC_017999; PRL2010, NC_014638; S17, NC_014616;
IPLA20015, from AMPM01000001 to AMPM01000050;
LMG13195, from AMPL01000001 to AMPL01000050). The
only exceptions were six chromosomal regions, three of which
are related to putative integrated phages or phage remnants
(Fig. 1A, regions A, C, and E) and two of which are related to
DNA modification enzymes (regions B and D); the other non-
conserved genetic locus (region F) consists of a 45-kb region,
which includes the putative genes of a type IV secretion system
(T4SS).
Even though T4SSs are widespread among all bacterial phyla,
their molecular component functions have been studied in depth
onlywithinGram-negative bacteria, such as the vir region ofAgro-
bacterium tumefaciens (35) and the cag type IV secretion apparatus
of Helicobacter pylori (36). The gene nomenclature of the 43-kbp
Agrobacterium virT4SS region has been used to refer also to T4SSs
identified in Gram-positive bacteria (37, 38).
We found 19 putative genes (Fig. 2A, ORFs 1 to 19) in the
predicted T4SS genetic locus of B. bifidum MIMBb75. These pu-
tative genes include theminimal components of the secretory sys-
tem in Gram-positive bacteria (VirB1-, VirB4-, VirB6-, and
VirD4-like proteins) and the proteins needed to support the con-
jugative transfer of DNA (37, 38). Specifically, we found in
MIMBb75 seven genes whose products contain conserved do-
mains associated to vir molecular components of the Agrobacte-
rium tumefaciens T4SS (Fig. 2A): ORF4 putatively codes for a
VirD2-like relaxase/mobilization protein (conserved domain
pfam03432) (Fig. 3, D2), whereas the polypeptide deduced from
ORF8 shows the conserved domains cd01126 and pfam12696,
which characterize TraG/TraD/VirD4-like proteins (Fig. 3, D4);
ORF11 shares homology with a VirB1-type lytic transglycosylase,
functioning to degrade peptidoglycan to facilitate insertion of the
Gram-positive bacterial type IV secretion machinery into the cell
envelope (38–40); the ORF12-encoded peptide contains a se-
quence homologous to the conserved domains pfam12846,
TIGR02746, and TIGR00929, which are typical of TrbE/VirB4-
like proteins (Fig. 3, B4). The VirB4- and VirD4-like enzymes of
the T4SSs are coupling proteinNTPases that play essential roles in
supplying the energy for substrate translocation and apparatus
assembly (31, 36, 41). ORF13 putatively codes for VirB6-like pro-
teins (Fig. 3, B6), which constitute a component of the transmem-
brane channel (16), whereasORF15 is the potential gene forVirC1
protein, a factor required for efficient DNA transfer (42). There-
fore, the 45-kb genetic locus of B. bifidum MIMBb75 seems to
have the main elements necessary for a functional type IV secre-
tion system (Fig. 3 describes the potential mechanism of DNA
transfer by the putative T4SS of B. bifidum MIMBb75).
TgaA Is a VirB1-Like Protein of B. biﬁdum MIMBb75
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ORF11 encodes TgaA, a putative VirB1-like enzyme. With
the aim of characterizing the putative T4SS of B. bifidum
MIMBb75, in this study we initially investigated ORF11, which
potentially corresponds to a VirB1-like protein. In the T4SS,
VirB1 is a protein that harbors a lysozyme-like structural fold.
Consistently, we found that the protein encoded by ORF11 con-
tains two conserved domains involved in the metabolism of the
bacterial cell wall, lytic murein transglycosylase (LT, cd00254.3)
and cysteine- and histidine-dependent amidohydrolase/peptidase
(CHAP, pfam05257.4) (Fig. 2B), according to an organization
that resembles the structure of autolytic enzymes (43, 44). Bacte-
rial lytic transglycosylases degrade murein by nonhydrolytic
cleavage of the -1,4-glycosidic bond between N-acetylmuramic
acid and N-acetylglucosamine and are part of the autolytic en-
zymes involved in controlled turnover of the bacterial cell wall (45,
46). The CHAP domain is found in a wide range of protein archi-
tectures, often in association with other domains that cleave pep-
tidoglycan (41, 47), and presumably showsN-acetylmuramoyl-L-
alanine amidase activity (48). Consequently, the putative gene
corresponding to ORF11 was named tgaA for transglycosylase
amidase gene A.
Distribution of TgaA protein in bifidobacteria. The overall
structure of the TgaA protein (i.e., the LT conserved domain
cd00254.3, followed by the CHAP domain pfam05257.4 at the C
terminus) was found in eight Bifidobacterium coding sequences
available in GenBank, including three putative proteins belonging
to the species B. breve and two belonging to B. bifidum. Besides the
above-mentioned eight sequences, the LT cassette was found in
only one additional putative protein (YP_004209100 from B.
longum subsp. infantis 157F) (see Fig. S4 in the supplemental ma-
terial), whereas a conserved domain of the CHAP superfamily was
identified in numerous bifidobacterial putative proteins and par-
ticularly in proteins where no other conserved domains are iden-
tified (see Fig. S4). The CHAP domain is, therefore, widespread
among bifidobacteria (18 species), indicating that its enzymatic
activity could be involved in cellular functions of fundamental
FIG 1 Comparative genomic analysis of B. bifidum MIMBb75 with other complete genome sequences of B. bifidum strains. (A) Circular genome atlas of B.
bifidum MIMBb75 (circle 1) with mapped orthologues (defined as reciprocal best BLASTP hits with more than 30% identity over at least 80% of both protein
lengths) in six publicly available B. bifidum genomes: B. bifidum PRL2010 (circle 2), B. bifidum S17 (circle 3), B. bifidum IPLA20015 (circle 4), B. bifidum
LMG13195 (circle 5), and B. bifidum BGN4 (circle 6). Circle 6 shows the GC plot, and circle 8 shows the GC skew. Highlighted in the atlas are the main regions
of difference between the genomes. (B)Heatmap showing genes encompassing the tgaA-containing region and conserved among the other sequenced B. bifidum
genomes. Yellow indicates the chromosomal regions homologous to the putative MIMBb75 T4SS, whereas black indicates the absence of homology.
Guglielmetti et al.
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importance for cell wall metabolism (44). Interestingly, about 14
protein spots in the extracellular proteome of B. animalis subsp.
lactis BB-12 were attributed to BIF_00825 and BIF_01398, two
proteins containing a CHAP amidase domain (49). In contrast, in
our study we failed to detect any significant positive signal when
we tested an MIMBb75 cell-free cMRS broth culture using West-
ern blot analysis with anti-CHAP polyclonal antibodies (data not
shown).
TgaA is a peptidoglycan lytic enzyme.We initially verified by
reverse transcription-PCR (RT-PCR) that the tgaA gene is ex-
pressed by B. bifidum MIMBb75 during the initial exponential
growth phase (see Fig. S1 in the supplemental material). Subse-
FIG 2 Organization of the putative type IV secretion system genetic region of Bifidobacterium bifidum MIMBb75 (A) and structural organization of the TgaA
protein (B). ORFs indicated in the map in panel A putatively code for the following proteins (according to a BLASTP search): 1, HipA-like domain-containing
protein (PF07805); 2, helix-turn-helix XRE family-like protein (HipB); 3, DNA topoisomerase III; 4, relaxase (VirD2); 5, mobilization protein (MobC); 6,
conserved transposon-encoded protein (TnpV); 7, methyl transferase type 11; 8, VirD4 ATPase (TraG/TraD family protein); 9, HipB transcriptional regulator
(HTHXRE); 10, molecular chaperone (containing the pfam02459motif); 11, TgaA (VirB1); 12, transfer complex protein (VirB4); 13, plasmid conjugal transfer
protein (VirB6/TrbL); 14, aggregation substance (containing domains pfam10698 and TIGR04228); 15, ParA ATPase (VirC1); 16, transcription regulator
WhiB-related protein; 17, acetyltransferase (GNAT) family; 18, HTHXRE (HipB, containing the domain cd00093); 19, HAD-type hydrolase (COG0561). ORFs
putatively coding for hypothetical proteins have not been included. oriT, putative origin of transfer. TM, transmembrane region.
FIG 3 Proposed mechanism of the putative type IV secretion system (T4SS) of Bifidobacterium bifidum MIMBb75. (The illustration is based on the scheme in
reference 51.) The numbers and codes of genes and proteins are according to Fig. 2A. CW, cell wall; CM, cell membrane. The T4SS is comprised of conjugation,
effector translocator, and DNA release/uptake subfamilies of proteins. For conjugative transfer, DNA substrates are processed through (i) excision from the
chromosome by excisionase/integrase enzymes or transposases (e.g., VirD2), (ii) processing of the transfer intermediate at the origin-of-transfer sequence (oriT)
by the relaxosome (e.g., ORF5 and ORF6), (iii) recruitment of the relaxase T-strand intermediate to the type IV coupling proteins (e.g., VirB4/D4), and (iv)
translocation through the T4SS channel (e.g., ORF14).
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quently, we prepared an engineered E. coli construct expressing a
recombinant form of TgaA (SPPelB-TgaA) on IPTG induction in
order to biologically confirm the enzymatic activity computation-
ally assigned to the protein TgaA. In SPPelB-TgaA, the original
signal peptide of TgaA was replaced by a pelB signal sequence for
export at the periplasmic level in E. coli (Fig. 4A). As an initial
confirmation of TgaA lytic activity, we observed a drasticmorpho-
logical modification of recombinant E. coli cells at the end of the
exponential growth phase (Fig. 4B), which was not detected in the
same E. coli strain harboring the empty vector pAK400. In addi-
tion, incubation for a few hours of a suspension of wild-type E. coli
XL1with purified SPPelB-TgaA protein resulted in a complete lysis
of the bacterial cells (Fig. 4C).
In a following experiment, we confirmed the lytic activity of
TgaA bymeans of a luminescence reporter system based on vector
pBlaLux1 (31). In pBlaLux1, the luxCDABE operon of Photorhab-
dus luminescens is under the control of the regulatory element
ampR-ampC of Citrobacter freundii (PampC), which was demon-
strated to be activated by peptidoglycan fragments (see Fig. S2 in
the supplemental material). The introduction of the vector ex-
FIG 5 Double expression reporter system for the determination of the pepti-
doglycan lytic activity of TgaA. A dose-dependent increase of bioluminescence
by IPTG induction in E. coli SNO301 containing pAK-tga and pBlaLux1 was
observed. The same strain containing only vector pBlaLux1 was used as a
control. The addition of IPTG to E. coli SNO301 containing only pBlaLux1
(and not pAK-tga) determined a reduction of the light emission (dotted lines).
RLU, relative luminescence units. Each point in the plot represents themean of
the values obtained in one representative experiment conducted in quadrupli-
cates. The variation between the replicates was less than 10%.
FIG 6 SDS-PAGE (a) and renaturing SDS-PAGE containing 0.2% autoclaved
M. luteus cells (b) of the purified six-His-tagged TgaA-derived recombinant
proteins. Lane 1, SP-TgaA-CHAP-His (rLT); lane 2, SP-TgaA-LT-His
(rCHAP). The relative molecular masses (in kDa) of standard proteins are
indicated on the left.
FIG 4 Determination of the cell wall lytic activity of TgaA protein. A recombinant form of TgaA (SPPelB-TgaA) was expressed in E. coli XL1 through vector
pAK-tga (A), resulting in altered cell morphology after 24 h of growth at 37°C in 2 YTmedium (B). After wild-type XL1 cells were incubated at 37°C for 4 h in
the presence of 50g of purified SPPelB-TgaA, the addition of 10% SDS to a final concentration of 0.2% determined instantaneous complete cell lysis (C). Vector
pAK-tga was obtained by cloning gene tgaA in the empty vector pAK400.
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pressing SPPelB-TgaA in themicrobial biosensor resulted in a dou-
ble expression system in which the addition of IPTG produced a
dose-dependent increase in bioluminescence (Fig. 5). This exper-
iment showed, therefore, that the intracellular expression of
SPPelB-TgaA can cause the accumulation in E. coli cells of pepti-
doglycan breakdown products, possibly originating from cell wall
lysis by TgaA.
Finally, purified SPPelB-TgaA displayed peptidoglycan lytic ac-
tivity in a renaturing SDS-PAGE assay with cell wall substrates
fromMicrococcus luteus (see Fig. S3 in the supplementalmaterial).
We ran the same experiment also with the two TgaA protein do-
mains (LT and CHAP), expressed separately by the preparation of
recombinant forms of TgaA through overexpression in E. coli.
Recombinant proteins lacked the original TgaA signal peptide and
were named as follows: proteinSP-TgaA-CHAP-His (contain-
ing only the LT domain; rLT) and SP-TgaA-LT-His (contain-
ing only the CHAP domain; rCHAP). Renaturing SDS-PAGE
analyses clearly showedTgaApeptidoglycan lytic activity predom-
inantly linked with the transglycosylase domain LT, as confirmed
by a distinct band corresponding to the position to which rLT had
migrated on SDS-PAGE (Fig. 6). In addition, the clarification de-
termined by the rCHAP, although faint, was detectable (Fig. 6).
These results agree with those of Arends et al., who found that
both the LT and CHAP domains can degrade peptidoglycan (40).
In conclusion, our results show unambiguously that the TgaA
protein displays peptidoglycan lytic enzymatic activity, which is
consistent with the supposed VirB1-like role of this enzyme.
Protein TgaA is expressed on the B. bifidum MIMBb75 cell
surface. The enzymatic activity of TgaA protein and its potential
role in the putative T4SS suggest its location at cell wall level.
Therefore, to confirm the presence and localization of the TgaA
protein in B. bifidum cells, we prepared rabbit polyclonal antibod-
ies against a purified recombinant form of TgaA protein. We first
studied the presence of TgaA in MIMBb75 cells by fluorescence
immunostaining with a goat anti-rabbit phycoerythrin (PE)-
Cy5.5 secondary antibody via fluorescence microscopy, which re-
vealed evident fluorescence emission by many cells, particularly
by cell aggregates (Fig. 7A).
In addition, to directly pinpoint TgaA in B. bifidumMIMBb75
cells, we ran experiments using immunogold transmission elec-
tron microscopy. The specificity of TgaA recognition by the anti-
bodies was demonstrated by the fact that cell staining was insig-
nificant when we immunolabeled B. bifidum PRL2010, a
bifidobacterial strain with no gene in its genome sharing signifi-
cant sequence similarity with tgaA. In contrast, the electron mi-
crographs showed numerous positive signals in the cytoplasm
and, particularly, associated with the cell wall of MIMBb75 (Fig.
7B and C). Gold particles were also partially distributed in an
extracellular matrix (Fig. 7B, frames c to f), which could indicate
either a molecule naturally produced by the bacterium (e.g., ex-
opolysaccharides) or cytoplasm extruded from bacterial cells dur-
ing sectioning. These data confirm that the TgaA protein is abun-
dantly expressed in B. bifidum MIMBb75. In particular,
FIG 7 Localization of the TgaA protein in B. bifidum MIMBb75 cells by im-
munofluorescence staining (A) and immunogold labeling (B and C). (A) Bac-
terial cells were probed with SP-TgaA-LT-His antiserum, followed by a
reaction with a Cy5-conjugated goat anti-rabbit secondary antibody. Cells
were visualized with a fluorescence microscope. Fluorescence, phase-contrast,
andmerged images of the bacterial cells in the same field are shown. The upper
pictures show free bacterial cells (scale bar, 5 m), whereas lower panels show
cell aggregates (scale bar, 10 m). (B and C) Bacterial cells were probed with
the SP-TgaA-LT-His antiserum, followed by interaction with gold (12-
nm)-conjugated goat anti-rabbit IgG, and negatively stained. We tested thin
sections of cell-embedded Lowicryl HM20 resin (B) and intact cells (C). Iden-
tifications for panel B are as follows: frame a, nonlabeled MIMBb75 cells;
frames b to f, B. bifidum MIMBb75; frames g to i, B. bifidum PRL2010. The
arrow in frame f indicates abundant staining of the MIMBb75 cell wall. Bac-
terial cells were visualized with a transmission electron microscope at a mag-
nification of 23,000 to 60,000.
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experiments with intact cells established unequivocally that TgaA
was present on the outer surface of the bacterial cells (Fig. 7B),
consistent with the role proposed for VirB1-like proteins in T4SS
(50).
Conclusions. The results of this study can be summarized as
follows: (i) the genomeofBifidobacteriumbifidumMIMBb75 con-
tains a 45-kb region that includes 19 putative genes coding for a
potential type IV secretion system; (ii) one gene of this region,
named tgaA, putatively encodes the VirB1-like protein of the sys-
tem, containing two enzymatic domains (lytic transglycosylase LT
and amidase CHAP) reportedly associated with peptidoglycan ly-
sis; (iii) we experimentally confirmed that protein TgaA, consis-
tent with its putative VirB1 role, has peptidoglycan lytic activity
and is abundantly expressed on the cell surface of B. bifidum
MIMBb75.
T4SSs have not been characterized before in bifidobacteria.
However, a database search revealed that a genetic region signifi-
cantly similar to MIMBb75’s putative T4SS is also present in the
genome of Bifidobacterium bifidum BGN4 (93% nucleotide iden-
tity) and Bifidobacterium longum subsp. infantis 157F (91%nucle-
otide identity). In this study, we undertook the initial character-
ization of this genetic region, which, according to the literature,
can have important implications for bacterial cell-to-cell commu-
nication as well as cross talk with host cells (19). In addition, the
localization and abundance of TgaA on the B. bifidum cell surface
support the hypothesis that this protein may potentially act as a
molecular pattern recognized by host cell receptors at the intesti-
nal level, justifying the interest for further studies aimed at the
investigation of the direct interaction of TgaA protein with host
cells. Accordingly, in a companion paper (32), we describe the
ability of TgaA protein domains to activate dendritic cell matura-
tion.
ACKNOWLEDGMENT
This work was financially supported by Fondazione Cariplo (grant 2010-
0678).
REFERENCES
1. Zivkovic AM, German JB, Lebrilla CB, Mills DA. 2011. Human milk
glycobiome and its impact on the infant gastrointestinalmicrobiota. Proc.
Natl. Acad. Sci. U. S. A. 108:4653–4658. http://dx.doi.org/10.1073/pnas
.1000083107.
2. Turroni F, Peano C, Pass DA, Foroni E, Severgnini M, Claesson MJ,
Kerr C, Hourihane J, Murray D, Fuligni F, Gueimonde M, Margolles A,
De Bellis G, O’Toole PW, van Sinderen D, Marchesi JR, Ventura M.
2012. Diversity of bifidobacteria within the infant gut microbiota. PLoS
One 7:e36957. http://dx.doi.org/10.1371/journal.pone.0036957.
3. Young SL, Simon MA, Baird MA, Tannock GW, Bibiloni R, Spencely K,
Lane JM, Fitzharris P, Crane J, Town I, Addo-Yobo E, Murray CS,
Woodcock A. 2004. Bifidobacterial species differentially affect expression
of cell surface markers and cytokines of dendritic cells harvested. Clin.
Diagn. Lab. Immunol. 11:686–690. http://dx.doi.org/10.1128/CDLI.11.4
.686-690.2004.
4. Menard O, Butel MJ, Gaboriau-Routhiau V, Waligora-Dupriet AJ.
2008. Gnotobiotic mouse immune response induced by Bifidobacterium
sp. strains isolated from infants. Appl. Environ. Microbiol. 74:660–666.
http://dx.doi.org/10.1128/AEM.01261-07.
5. Guglielmetti S, Tamagnini I, Mora D, Minuzzo M, Scarafoni A, Arioli S,
Hellman J, Karp M, Parini C. 2008. Implication of an outer surface lipopro-
tein in adhesion of Bifidobacterium bifidum to Caco-2 cells. Appl. Environ.
Microbiol. 74:4695–4702. http://dx.doi.org/10.1128/AEM.00124-08.
6. Guglielmetti S, Tamagnini I, Minuzzo M, Arioli S, Parini C, Comelli E,
Mora D. 2009. Study of the adhesion of Bifidobacterium bifidum
MIMBb75 to human intestinal cell lines. Curr. Microbiol. 59:167–172.
http://dx.doi.org/10.1007/s00284-009-9415-x.
7. Turroni F, Bottacini F, Foroni E, Mulder I, Kim JH, Zomer A, Sanchez
B, Bidossi A, Ferrarini A, Giubellini V, Delledonne M, Henrissat B,
Coutinho P, Oggioni M, Fitzgerald GF, Mills D, Margolles A, Kelly D,
van Sinderen D, Ventura M. 2010. Genome analysis of Bifidobacterium
bifidum PRL2010 reveals metabolic pathways for host-derived glycan for-
aging. Proc. Natl. Acad. Sci. U. S. A. 107:19514–19519. http://dx.doi.org
/10.1073/pnas.1011100107.
8. Wada J, Ando T, Kiyohara M, Ashida H, Kitaoka M, Yamaguchi M,
Kumagai H, Katayama T, Yamamoto K. 2008. Bifidobacterium bifidum
lacto-N-biosidase, a critical enzyme for the degradation of human milk
oligosaccharides with a type 1 structure. Appl. Environ. Microbiol. 74:
3996–4004. http://dx.doi.org/10.1128/AEM.00149-08.
9. Weiss G, Rasmussen S, Fink LN, Jarmer H, Nielsen BN, Frokiaer H.
2010. Bifidobacterium bifidum actively changes the gene expression profile
induced by Lactobacillus acidophilus in murine dendritic cells. PLoS One
5:e11065. http://dx.doi.org/10.1371/journal.pone.0011065.
10. Lopez P, Gonzalez-Rodriguez I, Gueimonde M, Margolles A, Suarez A.
2011. Immune response to Bifidobacterium bifidum strains support Treg/
Th17 plasticity. PLoS One 6:e24776. http://dx.doi.org/10.1371/journal
.pone.0024776.
11. Turroni F, Serafini F, Foroni E, Duranti S, Motherway MO, Taverniti
V, Mangifesta M, Milani C, Viappiani A, Roversi T, Sanchez B, Santoni
A, Gioiosa L, Ferrarini A, Delledonne M, Margolles A, Piazza L, Palanza
P, Bolchi A, Guglielmetti S, van Sinderen D, Ventura M. 2013. Role of
sortase-dependent pili ofBifidobacterium bifidum PRL2010 inmodulating
bacterium-host interactions. Proc. Natl. Acad. Sci. U. S. A. 110:11151–
11156. http://dx.doi.org/10.1073/pnas.1303897110.
12. FAO/WHO. 2002. Report of a joint FAO/WHO expert consultation on
guidelines for the evaluation of probiotics in food. World Health Organi-
zation and Food and Agriculture Organization of the United Nations,
London, Ontario, Canada.
13. Taverniti V, Guglielmetti S. 2011. The immunomodulatory properties of
probiotic microorganisms beyond their viability (ghost probiotics: pro-
posal of paraprobiotic concept). Genes Nutr. 6:261–274. http://dx.doi.org
/10.1007/s12263-011-0218-x.
14. Singh N, Arioli S, Wang A, Villa CR, Jahani R, Song YS, Mora D,
Guglielmetti S, Comelli EM. 2013. Impact of Bifidobacterium bifidum
MIMBb75 on mouse intestinal microorganisms. FEMS Microbiol. Ecol.
85:369–375. http://dx.doi.org/10.1111/1574-6941.12124.
15. Guglielmetti S, Mora D, Gschwender M, Popp K. 2011. Randomised
clinical trial: Bifidobacterium bifidumMIMBb75 significantly alleviates ir-
ritable bowel syndrome and improves quality of life—a double-blind, pla-
cebo-controlled study. Aliment. Pharmacol. Therap. 33:1123–1132. http:
//dx.doi.org/10.1111/j.1365-2036.2011.04633.x.
16. Juhas M, Crook DW, Hood DW. 2008. Type IV secretion systems: tools
of bacterial horizontal gene transfer and virulence. Cell. Microbiol. 10:
2377–2386. http://dx.doi.org/10.1111/j.1462-5822.2008.01187.x.
17. Hamilton HL, Dominguez NM, Schwartz KJ, Hackett KT, Dillard JP.
2005. Neisseria gonorrhoeae secretes chromosomal DNA via a novel type
IV secretion system. Mol. Microbiol. 55:1704–1721. http://dx.doi.org/10
.1111/j.1365-2958.2005.04521.x.
18. Lawley TD, Klimke WA, Gubbins MJ, Frost LS. 2003. F factor conjuga-
tion is a true type IV secretion system. FEMS Microbiol. Lett. 224:1–15.
http://dx.doi.org/10.1016/S0378-1097(03)00430-0.
19. Cascales E, Christie PJ. 2003. The versatile bacterial type IV secretion sys-
tems.Nat.Rev.Microbiol.1:137–149.http://dx.doi.org/10.1038/nrmicro753.
20. Goessweiner-Mohr N, Arends K, Keller W, Grohmann E. 2013. Con-
jugative type IV secretion systems in Gram-positive bacteria. Plasmid 70:
289–302. http://dx.doi.org/10.1016/j.plasmid.2013.09.005.
21. Christie PJ, Atmakuri K, Krishnamoorthy V, Jakubowski S, Cascales E.
2005. Biogenesis, architecture, and function of bacterial type IV secretion
systems. Annu. Rev. Microbiol. 59:451–485. http://dx.doi.org/10.1146
/annurev.micro.58.030603.123630.
22. Zerbino DR, Birney E. 2008. Velvet: Algorithms for de novo short read
assembly using de Bruijn graphs. Genome Res. 18:821–829. http://dx.doi
.org/10.1101/gr.074492.107.
23. Hyatt D, Chen GL, Lo Cascio PF, Land ML, Larimer FW, Hauser LJ.
2010. Prodigal: prokaryotic gene recognition and translation initiation site
identification. BMC Bioinformatics 11:119. http://dx.doi.org/10.1186
/1471-2105-11-119.
24. Gish W, States DJ. 1993. Identification of protein coding regions by
database similarity search. Nat. Genet. 3:266–272. http://dx.doi.org/10
.1038/ng0393-266.
Guglielmetti et al.
5168 aem.asm.org Applied and Environmental Microbiology
 o
n
 August 8, 2014 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
25. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local
alignment search tool. J. Mol. Biol. 215:403–410. http://dx.doi.org/10
.1016/S0022-2836(05)80360-2.
26. Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream MA,
Barrell B. 2000. Artemis: sequence visualization and annotation. Bioinfor-
matics 16:944–945. http://dx.doi.org/10.1093/bioinformatics/16.10.944.
27. Krogh A, Larsson B, von Heijne G, Sonnhammer ELL. 2001. Predicting
transmembrane protein topology with a hidden Markov model: applica-
tion to complete genomes. J. Mol. Biol. 305:567–580. http://dx.doi.org/10
.1006/jmbi.2000.4315.
28. Bendtsen JD, Nielsen H, von Heijne G, Brunak S. 2004. Improved
prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340:783–795. http:
//dx.doi.org/10.1016/j.jmb.2004.05.028.
29. Arioli S, Ragg E, Scaglioni L, Fessas D, Signorelli M, Karp M, Daffon-
chio D, De Noni I, Mulas L, Oggioni M, Guglielmetti S, Mora D. 2010.
Alkalizing reactions streamline cellular metabolism in acidogenic micro-
organisms. PLoS One 5:e15520. http://dx.doi.org/10.1371/journal.pone
.0015520.
30. Krebber A, Bornhauser S, Burmester J, Honegger A, Willuda J,
Bosshard HR, Pluckthun A. 1997. Reliable cloning of functional antibody
variable domains from hybridomas and spleen cell repertoires employing
a reengineered phage display system. J. Immunol. Methods 201:35–55.
http://dx.doi.org/10.1016/S0022-1759(96)00208-6.
31. Valtonen SJ, Kurittu JS, Karp MT. 2002. A luminescent Escherichia coli
biosensor for the high throughput detection of beta-lactams. J. Biomol.
Screen. 7:127–134. http://dx.doi.org/10.1177/108705710200700205.
32. Guglielmetti S, Zanoni I, Balzaretti S, Miriani M, Taverniti V, De Noni
I, Presti I, Stuknyte M, Scarafoni A, Arioli S, Iametti S, Bonomi F, Mora
D, Karp M, Granucci F. 2014. Murein lytic enzyme TgaA of Bifidobacte-
rium bifidum MIMBb75 modulates dendritic cell maturation through its
cysteine- and histidine-dependent amidohydrolase/peptidase (CHAP)
amidase domain. Appl. Environ. Microbiol. 80:5170–5177. http://dx.doi
.org/10.1128/AEM.00761-14.
33. Mora D, Musacchio F, Fortina MG, Senini L, Manachini PL. 2003.
Autolytic activity and pediocin-induced lysis in Pediococcus acidilactici
and Pediococcus pentosaceus strains. J. Appl. Microbiol. 94:561–570. http:
//dx.doi.org/10.1046/j.1365-2672.2003.01868.x.
34. Arioli S, Roncada P, Salzano AM, Deriu F, Corona S, Guglielmetti S,
Bonizzi L, Scaloni A, Mora D. 2009. The relevance of carbon dioxide
metabolism in Streptococcus thermophilus. Microbiology 155:1953–1965.
http://dx.doi.org/10.1099/mic.0.024737-0.
35. Stachel SE, Nester EW. 1986. The genetic and transcriptional organiza-
tion of the Vir region of the A6-Ti plasmid of Agrobacterium tumefaciens.
EMBO J. 5:1445–1454.
36. Terradot L, Waksman G. 2011. Architecture of the Helicobacter pylori
Cag-type IV secretion system. FEBS J. 278:1213–1222. http://dx.doi.org
/10.1111/j.1742-4658.2011.08037.x.
37. Abajy MY, Kopec J, Schiwon K, Burzynski M, Doring M, Bohn C,
Grohmann E. 2007. A type IV-secretion-like system is required for con-
jugative DNA transport of broad-host-range plasmid pIP501 in gram-
positive bacteria. J. Bacteriol. 189:2487–2496. http://dx.doi.org/10.1128
/JB.01491-06.
38. Zhang W, Rong CB, Chen C, Gao GF. 2012. Type-IVC secretion system:
a novel subclass of type IV secretion system (T4SS) common existing in
Gram-positive genus Streptococcus. PLoS One 7:e46390. http://dx.doi.org
/10.1371/journal.pone.0046390.
39. Fronzes R, Schäfer E, Wang L, Saibil HR, Orlova EV, Waksman G.
2009. Structure of a type IV secretion system core complex. Science 323:
266–268. http://dx.doi.org/10.1126/science.1166101.
40. Arends K, Celik EK, Probst I, Goessweiner-Mohr N, Fercher C, Grumet
L, Soellue C, Abajy MY, Sakinc T, Broszat M, Schiwon K, Koraimann
G, Keller W, Grohmann E. 2013. TraG encoded by the pIP501 type IV
secretion system is a two-domain peptidoglycan-degrading enzyme essen-
tial for conjugative transfer. J. Bacteriol. 195:4436–4444. http://dx.doi.org
/10.1128/JB.02263-12.
41. Pritchard DG, Dong SL, Baker JR, Engler JA. 2004. The bifunctional
peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. Micro-
biology 150:2079–2087. http://dx.doi.org/10.1099/mic.0.27063-0.
42. Atmakuri K, Cascales E, Burton OT, Banta LM, Christie PJ. 2007.
Agrobacterium ParA/MinD-like VirC1 spatially coordinates early conju-
gative DNA transfer reactions. EMBO J. 26:2540–2451. http://dx.doi.org
/10.1038/sj.emboj.7601696.
43. Rigden DJ, Jedrzejas MJ, Galperin MY. 2003. Amidase domains from
bacterial and phage autolysins define a family of gamma-D,L-glutamate-
specific amidohydrolases. Trends Biochem. Sci. 28:230–234. http://dx.doi
.org/10.1016/S0968-0004(03)00062-8.
44. Bateman A, Rawlings ND. 2003. The CHAP domain: a large family of
amidases including GSP amidase and peptidoglycan hydrolases.
Trends Biochem. Sci. 28:234–237. http://dx.doi.org/10.1016/S0968
-0004(03)00061-6.
45. Engel H, Kazemier B, Keck W. 1991. Murein-metabolizing enzymes
from Escherichia coli—sequence-analysis and controlled overexpression
of the Slt gene, which encodes the soluble lytic transglycosylase. J. Bacte-
riol. 173:6773–6782.
46. van Asselt EJ, Dijkstra AJ, Kalk KH, Takacs B, Keck W, Dijkstra BW.
1999. Crystal structure of Escherichia coli lytic transglycosylase Slt35 re-
veals a lysozyme-like catalytic domainwith an EF-hand. Structure 7:1167–
1180. http://dx.doi.org/10.1016/S0969-2126(00)80051-9.
47. Kausmally L, Johnsborg O, Lunde M, Knutsen E, Havarstein LS. 2005.
Choline-binding protein D (CbpD) in Streptococcus pneumoniae is essen-
tial for competence-induced cell lysis. J. Bacteriol. 187:4338–4345. http:
//dx.doi.org/10.1128/JB.187.13.4338-4345.2005.
48. Loessner MJ, Gaeng S, Wendlinger G, Maier SK, Scherer S. 1998. The
two-component lysis system of Staphylococcus aureus bacteriophage
Twort: a large TTG-start holin and an associated amidase endolysin.
FEMS Microbiol. Lett. 162:265–274. http://dx.doi.org/10.1111/j.1574
-6968.1998.tb13008.x.
49. Gilad O, Svensson B, Viborg AH, Stuer-Lauridsen B, Jacobsen S. 2011.
The extracellular proteome of Bifidobacterium animalis subsp. lactis BB-12
reveals proteins with putative roles in probiotic effects. Proteomics 11:
2503–2514. http://dx.doi.org/10.1002/pmic.201000716.
50. Aguilar J, Cameron TA, Zupan J, Zambryski P. 2011. Membrane and
core periplasmic Agrobacterium tumefaciens virulence Type IV secretion
system components localize to multiple sites around the bacterial perim-
eter during lateral attachment to plant cells. mBio 2(6):e00218-11. http:
//dx.doi.org/10.1128/mBio.00218-11.
51. Alvarez-Martinez CE, Christie PJ. 2009. Biological diversity of prokary-
otic type IV secretion systems. Microbiol. Mol. Biol. Rev. 73:775–808.
http://dx.doi.org/10.1128/MMBR.00023-09.
TgaA Is a VirB1-Like Protein of B. biﬁdum MIMBb75
September 2014 Volume 80 Number 17 aem.asm.org 5169
 o
n
 August 8, 2014 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
